Providing instant access to compound data to interpret, model and guide drug discovery decisions CAMBRIDGE, UK – Optibrium™, a developer of software for small molecule drug discovery and optimisation, today announced the commercial launch of a database Query Interface for users of the company’s StarDrop software. The new tool provides an adaptable interface between an [...]

? First to represent Cerilliant® portfolio in reference standards of endogenous protein biomarkers ? Suitable for critical diagnostic testing applications by liquid chromatography, mass spectrometry Darmstadt, Germany — Merck, a leading science and technology company, today introduced the first Certified Spiking Solution® of intact, heavy labeled Thyroglobulin in SigMatrix®, a synthetic surrogate serum. The matrix-based [...]

• Merck on track to achieve objectives for 2018 • Pharma pipeline offers new sales potential of around € 2 billion up to 2022 • Sigma-Aldrich integration will exceed synergy targets by € 20 million thanks to additional top-line synergies • Performance Materials strengthens its market position through investments and is planning the launch of [...]

Sequel Systems to Be Used for High-Quality Vertebrate Genome Assemblies MENLO PARK, Calif. -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), today announced the Genome 10K (G10K) and Bird 10,000 Genomes (B10K) initiatives have invested in SMRT® Sequencing to be included as one of the technologies for the next phase of their vertebrate genome assembly programs. [...]

Peking Union Medical College Hospital in Beijing and Keio University in Tokyo are the newest members of Certara’s elite global pharmacometrics network PRINCETON, NJ – Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that Peking Union Medical College (PUMC) Hospital in Beijing, [...]

The GeneInsight-powered platform advances molecular informatics initiatives TUSCON, Ariz. – Sunquest Information Systems Inc. today announced that Nationwide Children’s Hospital Institute for Genomic Medicine Clinical Laboratory, MedComp Sciences and the University of Minnesota Health Fairview are now members of the VariantWire® data sharing initiative. GeneInsight®, a Sunquest company, supports the VariantWire networking infrastructure and crowdsourcing [...]

Peta-base sequencing, advanced informatics and regulatory preparation; for immuno-oncology clinical trials & other applications. Menlo Park, CA – Personalis, Inc., a precision medicine company focused on genomics solutions for immuno-oncology, targeted therapy, and genetic disease, today announced steps to increase the scale of its operations in 2017. These plans include three main elements: Sequencing scale: [...]

VALENCIA, Spain BioBam announced the new version of Blast2GO, a bioinformatics solution for the functional analysis of transcriptomics datasets. Blast2GO 4 has been announced as end-to-end solution for straightforward functional analysis of non-model organisms. The presented solution allows the functional annotation, analysis and biological interpretation of de-novo sequencing datasets. Dr. Stefan Götz, CEO at BioBam, [...]

Creates a Robust Diagnostic Platform Focused on Improving Accuracy of Cancer Diagnoses OMAHA, Neb. and NEW HAVEN, Conn. -- Transgenomic, Inc. (NASDAQ: TBIO), and privately-held Precipio Diagnostics, LLC today announced entry into a merger agreement, pursuant to which Precipio will become a wholly owned subsidiary of Transgenomic, and Transgenomic will be renamed Precipio, Inc. In [...]

- New technology selected for use by multiple human and non-human genome projects - Company to feature presentations on human and non-human projects at American Society of Human Genetics Meeting PLEASANTON, Calif. – 10x Genomics, a company focused on improving and broadening the application of genomic information, today announced the commercial availability of their new [...]